Abstract
Background
Blood trafficking from fetus to mother and vice versa is a well-known physiological event that occurs at any stage in pregnancy. If the fetus looses high blood quantities to the maternal blood stream it becomes symptomatic. These symptoms can vary from cardiovascular distress to fetal death.
Materials and methods
We give a review of current literature on Fetomaternal hemorrhage (FMH).
Conclusion
This article highlights the importance of physician’s awareness on detecting this rare but life threatening entity with both severe consequences for mother and neonate. The traditional measurement of FMH and the co-usage of alpha-fetoprotein are debated. To conclude we describe and discuss an illustrative case of FMH. This article gives an applicatory overview of symptoms, diagnostics and treatment of FMH to facilitate physicians to detect this disease precociously.
Similar content being viewed by others
References
Wylie BJ, D’Alton ME (2010) Fetomaternal hemorrhage. Obstet Gynecol 115:1039–1051
Sohda S, Samura O, Johnson LK, Falco VM, Elmes RS, Bianchi DW (2002) Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood. Prenat Diagn 22:1213–1218
Lindenburg I, van Kamp I, Oepkes D (2014) Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 14:1015–3837
Sueters M, Arabin B, Oepkes D (2003) Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage. Ultrasound Obstet Gynecol 22:186–189
Kecskes Z (2003) Large fetomaternal hemorrhage: clinical presentation and outcome. J Matern Fetal Neonatal Med 12:128–132
Manolopulos K, Künzel W (2001) Die Herzfrequenz des Feten bei fetomaternaler Transfusion. Gynäkologie 34:333–338
Herold G (2012) Innere Medizin
Stefanovic V, Paavonen J, Halmesmäki E, Luukkainen P, Tikkanen M, Nuutila M, Poikkeus P (2013) Two intrauterine transfusions in treatment of severe fetomaternal hemorrhage in the early third trimester. Clin Case Rep 1(2):59–62
Banerjee K, Kriplani A, Kumar V, Rawat KS, Kabra M (2004) Detecting fetomaternal hemorrhage after first-trimester abortion with the Kleihauer-Betke test and rise in maternal serum alpha-fetoprotein. J Reprod Med 49:205–209
Kadooka M, Kato H, Kato A, Ibhara S, Minakami H, Maruyama Y (2014) Effect of neonatal hemoglobin concentration on long-term outcome of infants affected by fetomaternal hemorrhage. Early Hum Dev 90:431–434
Shields LE, Widness JA, Brace RA (1993) Restoration of fetal red blood cells and plasma proteins after a moderately severe hemorrhage in ovine fetus. Am J Obstet Gynecol 169:1472–1478
Brace RA, Cheung CY (1990) Fetal blood volume restoration following rapid fetal hemorrhage. Am J Physiol 259:567–573
Naeslund J, Nylin G (1946) Investigation of permeability of placenta wit aid of red corpuscules tagged with radioactive phosphorus. Acta Med Scand 170:385–388
Mengert WF, Rights CS, Bates CR Jr, Reid AF, Wolf GR, Nabor GC (1955) Placental transmission of erythrocytes. Am J Obstet Gynecol 69:678–685
Macris NT, Hellman LM, Watson RJ (1958) The transmission of transfused sickle-trait cells from mother to fetus. Am J Obstet Gynecol 1214–1418
Henningsen A-K A, Maroun LL, Havsteen H, Svare J (2010) Massive Fetomaternal Hemorrhage Caused by an Intraplacental Chorioncarcinoma: a case report. Case Rep Med
Touboul C, Faivre E, Boithias C, Mass AE, Senat MV, Fernandez H, Deffieux X (2010) fetomaternal hemorrhage cause by intraplacental chorioncarcinoma. J Gynecol Obstet Biol Reprod (Paris) 39:156–158
Kleihauer B, Braun H, Betke H (1957) Demostration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr 154:1363–1369
Kim Y, Makar R (2012) Detection of fetomaternal hemorrhage. Am J Hematol 87:417–423
De Almeida V, Bowman JM (1994) Massive fetomaternal hemorrhage: manitoba experience. Obstet Gynecol 83:323–328
Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, Schonewille H, Doxiadis II, Kanhai HH, van Lith JM, van Zwet EW, Oepkes D, Brand A, Lopriore E, LOTUS study group (2012) Long-term neurodevelopemental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. AM J Obstet Gynecol 206
Adams KM, Nelson JL (2004) Microchimerism: an investigative frontier on autoimmunity and transplantation. JAMA 291:1127–1131
Solano ME, Thiele K, Stelzer IA, Mittrücker HW, Arck PC (2014) Advancing the detection of maternal haematopoietic microchimeric cells in fetal immune organs in mice by flow cytometry. Chomerism 30
Van Selm M, Kanhai HH, Van Loon AJ (1995) Detection of fetomaternal hemorrhage associated with cordocentesis using serum alpha-fetoprotein and the Kleihauer technique. Prenat Diagn 15:313–316
Hida S (1989) Measurement of alpha-fetoprotein and fetal erythrocyte levels for detecting fetomaternal hemorrhage. Asia Oceania J Obstet Gynaecol 15:41–45
Murphy KW, Venkatraman N, Stevens J (2000) Limitations of ultrasound in the diagnosis of fetomaternal hemorrhage. Br J Obstet Gynaecol 107:1317–1319
Stroustrup A, Plafkin C, Savitz D (2014) Impact of Physician Awareness on Diagnosis of Fetomaternal Hemorrhage. Neonatology 105:250–255
Sueters M, Arabin B, Oepkes D (2003) Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage. Ultrasound Obstet Gynecol 22:186–189
Conflict of interest
The authors state that they have no conflict of interest as well as full control of all data. We allow the journal to review our data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maier, J.T., Schalinski, E., Schneider, W. et al. Fetomaternal hemorrhage (FMH), an update: review of literature and an illustrative case. Arch Gynecol Obstet 292, 595–602 (2015). https://doi.org/10.1007/s00404-015-3686-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-015-3686-1